335 related articles for article (PubMed ID: 17043277)
1. The therapeutic efficacy of edaravone in extensively burned rats.
Koizumi T; Tanaka H; Sakaki S; Shimazaki S
Arch Surg; 2006 Oct; 141(10):992-5. PubMed ID: 17043277
[TBL] [Abstract][Full Text] [Related]
2. Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo.
Inokuchi Y; Imai S; Nakajima Y; Shimazawa M; Aihara M; Araie M; Hara H
J Pharmacol Exp Ther; 2009 May; 329(2):687-98. PubMed ID: 19201991
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of the free radical scavenger edaravone on acute pancreatitis-associated lung injury.
Yang T; Mao YF; Liu SQ; Hou J; Cai ZY; Hu JY; Ni X; Deng XM; Zhu XY
Eur J Pharmacol; 2010 Mar; 630(1-3):152-7. PubMed ID: 20035747
[TBL] [Abstract][Full Text] [Related]
4. Edaravone attenuates white matter lesions through endothelial protection in a rat chronic hypoperfusion model.
Ueno Y; Zhang N; Miyamoto N; Tanaka R; Hattori N; Urabe T
Neuroscience; 2009 Aug; 162(2):317-27. PubMed ID: 19409967
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of edaravone on experimental spinal cord injury in rats.
Ozgiray E; Serarslan Y; Oztürk OH; Altaş M; Aras M; Söğüt S; Yurtseven T; Oran I; Zileli M
Pediatr Neurosurg; 2011; 47(4):254-60. PubMed ID: 22310070
[TBL] [Abstract][Full Text] [Related]
6. Free radical scavenger (edaravone) prevents endotoxin-induced liver injury after partial hepatectomy in rats.
Tsuji K; Kwon AH; Yoshida H; Qiu Z; Kaibori M; Okumura T; Kamiyama Y
J Hepatol; 2005 Jan; 42(1):94-101. PubMed ID: 15629513
[TBL] [Abstract][Full Text] [Related]
7. Acute urinary retention and subsequent catheterization cause lipid peroxidation and oxidative DNA damage in the bladder: preventive effect of edaravone, a free-radical scavenger.
Shimizu S; Saito M; Kinoshita Y; Kazuyama E; Tamamura M; Satoh I; Satoh K
BJU Int; 2009 Sep; 104(5):713-7. PubMed ID: 19338546
[TBL] [Abstract][Full Text] [Related]
8. Edaravone, a newly developed radical scavenger, protects against ischemia-reperfusion injury of the small intestine in rats.
Tomatsuri N; Yoshida N; Takagi T; Katada K; Isozaki Y; Imamoto E; Uchiyama K; Kokura S; Ichikawa H; Naito Y; Okanoue T; Yoshikawa T
Int J Mol Med; 2004 Jan; 13(1):105-9. PubMed ID: 14654979
[TBL] [Abstract][Full Text] [Related]
9. Edaravone reduces myocardial infarct size and improves cardiac function and remodelling in rabbits.
Onogi H; Minatoguchi S; Chen XH; Bao N; Kobayashi H; Misao Y; Yasuda S; Yamaki T; Maruyama R; Uno Y; Arai M; Takemura G; Fujiwara H
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1035-41. PubMed ID: 17042911
[TBL] [Abstract][Full Text] [Related]
10. Electron spin resonance and spin trapping technique provide direct evidence that edaravone prevents acute ischemia-reperfusion injury of the liver by limiting free radical-mediated tissue damage.
Kono H; Woods CG; Maki A; Connor HD; Mason RP; Rusyn I; Fujii H
Free Radic Res; 2006 Jun; 40(6):579-88. PubMed ID: 16753835
[TBL] [Abstract][Full Text] [Related]
11. Edaravone (MCI-186), a free radical scavenger, attenuates retinal ischemia/reperfusion injury in rats.
Song Y; Gong YY; Xie ZG; Li CH; Gu Q; Wu XW
Acta Pharmacol Sin; 2008 Jul; 29(7):823-8. PubMed ID: 18565280
[TBL] [Abstract][Full Text] [Related]
12. Preventive effects of edaravone, a free radical scavenger, on lipopolysaccharide-induced lung injury in mice.
Tajima S; Soda M; Bando M; Enomoto M; Yamasawa H; Ohno S; Takada T; Suzuki E; Gejyo F; Sugiyama Y
Respirology; 2008 Sep; 13(5):646-53. PubMed ID: 18713088
[TBL] [Abstract][Full Text] [Related]
13. The free radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cells.
Kikuchi K; Kawahara K; Tancharoen S; Matsuda F; Morimoto Y; Ito T; Biswas KK; Takenouchi K; Miura N; Oyama Y; Nawa Y; Arimura N; Iwata M; Tajima Y; Kuramoto T; Nakayama K; Shigemori M; Yoshida Y; Hashiguchi T; Maruyama I
J Pharmacol Exp Ther; 2009 Jun; 329(3):865-74. PubMed ID: 19293391
[TBL] [Abstract][Full Text] [Related]
14. Treatment with edaravone improves the survival rate in renal warm ischemia-reperfusion injury using rat model.
Matsuyama M; Hayama T; Funao K; Tsuchida K; Takemoto Y; Sugimura K; Kawahito Y; Sano H; Nakatani T; Yoshimura R
Transplant Proc; 2006 Sep; 38(7):2199-200. PubMed ID: 16980041
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment with edaravone reduces lung mitochondrial damage in an infant rabbit ischemia-reperfusion model.
Qiu W; Gu H; Zheng L; Zhou J; Chen D; Chen Y
J Pediatr Surg; 2008 Nov; 43(11):2053-60. PubMed ID: 18970940
[TBL] [Abstract][Full Text] [Related]
16. Edaravone inhibits lipid peroxidation in neonatal hypoxic-ischemic rats: an in vivo microdialysis study.
Noor JI; Ueda Y; Ikeda T; Ikenoue T
Neurosci Lett; 2007 Feb; 414(1):5-9. PubMed ID: 17280782
[TBL] [Abstract][Full Text] [Related]
17. Edaravone attenuates ischemia-reperfusion injury by inhibiting oxidative stress in a canine lung transplantation model.
Xu JZ; Shen BZ; Li Y; Zhang T; Xu WH; Liu XW; Lu HG
Chin Med J (Engl); 2008 Aug; 121(16):1583-7. PubMed ID: 18982873
[TBL] [Abstract][Full Text] [Related]
18. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy.
Saini AK; Kumar H S A; Sharma SS
Eur J Pharmacol; 2007 Jul; 568(1-3):164-72. PubMed ID: 17521626
[TBL] [Abstract][Full Text] [Related]
19. Edaravone attenuates cerebral ischemic injury by suppressing aquaporin-4.
Kikuchi K; Tancharoen S; Matsuda F; Biswas KK; Ito T; Morimoto Y; Oyama Y; Takenouchi K; Miura N; Arimura N; Nawa Y; Meng X; Shrestha B; Arimura S; Iwata M; Mera K; Sameshima H; Ohno Y; Maenosono R; Tajima Y; Uchikado H; Kuramoto T; Nakayama K; Shigemori M; Yoshida Y; Hashiguchi T; Maruyama I; Kawahara K
Biochem Biophys Res Commun; 2009 Dec; 390(4):1121-5. PubMed ID: 19737535
[TBL] [Abstract][Full Text] [Related]
20. Beyond neurological disease: new targets for edaravone (Review).
Kikuchi K; Uchikado H; Miyagi N; Morimoto Y; Ito T; Tancharoen S; Miura N; Miyata K; Sakamoto R; Kikuchi C; Iida N; Shiomi N; Kuramoto T; Kawahara K
Int J Mol Med; 2011 Dec; 28(6):899-906. PubMed ID: 21922128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
